NCT03582917 The Role of VitD in Rehabilitation of Idiopathic Adolescent Scoliosis
| NCT ID | NCT03582917 |
| Status | Recruiting |
| Phase | Phase 2 |
| Sponsor | University of Ioannina |
| Condition | Scoliosis; Adolescence |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2018-09-20 |
| Primary Completion | 2025-12-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
In Phase 2, researchers evaluate early signs of effectiveness. You may be randomized to receive the active treatment or a comparator. Monitoring continues closely.
This trial targets 80 participants in total. It began in 2018-09-20 with a primary completion date of 2025-12-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this current prospective study is to determine the role of vitamin D in the development and restoration of spinal deformities in adolescence.
Eligibility Criteria
Inclusion Criteria: * Idiopathic Adolescent Scoliosis * Risser sign \<3-4 Exclusion Criteria: * Neuromuscular diseases * metabolic disease * Liver, lung, thyroid and parathyroid gland disorders.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03582917 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 18 Years, studying Scoliosis; Adolescence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT03582917 trial and what does that mean for participants?
Phase 2 trials evaluate whether the treatment shows signs of effectiveness while continuing to monitor safety. More participants are enrolled than in Phase 1 to help refine the treatment protocol.
Is NCT03582917 currently recruiting?
Yes, NCT03582917 is actively recruiting participants. Contact the research team at akissdoc@hotmail.com for enrollment information.
Where is the NCT03582917 trial being conducted?
This trial is being conducted at Asvestochóri, Greece, Ioannina, Greece.
Who is sponsoring the NCT03582917 clinical trial?
NCT03582917 is sponsored by University of Ioannina. The trial plans to enroll 80 participants.